ABSTRACT
Pharmaceutical and biotechnology companies are facing increasing global competition coupled with the need to maintain high market capitalization values. This has created a tremendous sense of urgency for them to look for ways to improve their efficiencies and reduce the cycle time of the drug discovery process.
